# Connectivity Affecting the Antidepressant REsponse Study

> **NCT02332291** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Bupropion XL

## Key facts

- **NCT ID:** NCT02332291
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332291, "Connectivity Affecting the Antidepressant REsponse Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02332291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*